FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Heritage Pharmaceuticals GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets Recall

GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2

Heritage Pharmaceuticals, Inc. · Eatontown, NJ

Risk level
Class II
Reported by FDA
Apr 15, 2015
Recall ID
D-0436-2015
Check your lot numberHow we source this data

Summary

Heritage Pharmaceuticals recalled GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets starting Mar 25, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0436-2015 on Apr 15, 2015. Reason: Failed Impurities/Degradation Specifications: Out of specification for unknown impurity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.

Product description

GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724, NDC: 23155-116-01.

Lot numbers, UPCs & expiration codes

Lot #:18020994, Expiry: October 2015; Lot #: 18021311, Expiry: November 2015.

Where it was sold

U.S. Nationwide including Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0436-2015
Classification
Class II
Status
Terminated
Recall initiated
Mar 25, 2015
FDA report date
Apr 15, 2015
Quantity
6,816 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Heritage Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0436-2015, exactly as published.

Show all FDA fields
City
Eatontown
State
NJ
Status
Terminated
Country
United States
Event ID
70845
Address
12 Christopher Way Ste 300
Code information
Lot #:18020994, Expiry: October 2015; Lot #: 18021311, Expiry: November 2015.
Postal code
07724-3331
Report date
Apr 15, 2015
Product type
Drugs
Recall number
D-0436-2015
Classification
Class II
Recalling firm
Heritage Pharmaceuticals, Inc.
Product quantity
6,816 Bottles
Termination date
May 15, 2017
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724, NDC: 23155-116-01.
Distribution pattern
U.S. Nationwide including Puerto Rico.
Recall initiation date
Mar 25, 2015
Initial firm notification
Letter
Center classification date
Apr 7, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0436-2015, published Apr 15, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls